FDA

• Conduct of Clinical Trials of Medical Products during the COVID-19 Public Health Emergency (updated Guidance, dated 27 Janury 2021)                        Conduct-of-Clincial-Trial-During-COVID_19-QA_Updated_01-27-21.pdf
• E-signatures clarified in FDA’s COVID-19 clinical trial guidance -                                                                                                                                            https://www.raps.org/news-and-articles/news-articles/2020/6/e-signatures-clarified-in-fdas-covid-19-clinical-t
• "FDA COVID-19 Response" (14 April 2020) -                                                                                                                                                    https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-and-emerging-threats/coronavirus-disease-2019-covid-19
• "FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic" -                                                               https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-pandemic